Details of the Drug Reposition

General Information of This Drug (ID: DMKA7H3)

Drug Name
Cresemba   DMKA7H3
Synonyms
Isavuconazonium sulfate; 946075-13-4; BAL-8557-002; Isavuconazonium sulfate [USAN]; CHEBI:85977; Isavuconazonium sulfate (USAN); UNII-31Q44514JV; BAL8557-002; 31Q44514JV; CHEMBL3137333; MolPort-044-559-915; AKOS030527357; Glycine, N-methyl-, (2-(((1-(1-((2R,3R)-3-(4-(4-cyanophenyl)-2-thiazolyl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4H-1,2,4-triazolium-4-yl)ethoxy)carbonyl)methylamino)-3-pyridinyl)methyl ester, sulfate (1:1); AS-35043; SC-12899; 1-((2R,3R)-3-(4-(4-Cyanophenyl)-1,3-thiazol-2-yl)-2-(2,5-difluorophe
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Invasive aspergillosis DISAI029 1F20.0 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Haematological malignancy DISCDP7W 2B33.Y Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03471988) Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)